Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04478071
Recruitment Status : Completed
First Posted : July 20, 2020
Last Update Posted : February 17, 2023
Akebia Therapeutics Inc.
United States Department of Defense
Information provided by (Responsible Party):
Bentley J. Bobrow, The University of Texas Health Science Center, Houston

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 7, 2022
Actual Study Completion Date : March 7, 2022
Certification/Extension First Submitted : February 14, 2023